ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Ful tanımlama

Detaylı Bibliyografya
Yazar: R.T. Saygitov
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: "Paediatrician" Publishers LLC 2008-08-01
Seri Bilgileri:Вопросы современной педиатрии
Online Erişim:https://vsp.spr-journal.ru/jour/article/view/1441